Results per Page:
SARS-CoV-2 vaccine efficacy in Latin American countries
From the Gilbert Group, Vaccine and Infectious Disease and Public Health Sciences Divisions
Do our own bugs determine our response to vaccines? – Likely yes!
From the Kublin lab, Vaccine and Infectious Disease Division
A win for vaccines: immune correlates identified for COVID-19
From the Fong, Gilbert, and collaborating labs, Vaccine and Infectious Disease Division & Public Health Sciences Division
Community virus surveillance can double the data of vaccine trials
From Mr. Craig Magaret, Vaccine and Infectious Disease Division
Fred Hutch at CROI: COVID-19 vaccine efficacy trials, T-cell immunity following vaccination, immune responses to SARS-CoV-2, and late-breaking science on HPV, HIV and long-term antiretroviral therapy
Conference on Retroviruses and Opportunistic Infections to be held virtually March 6 – 10, 2021
New study looks at how persistent organic pollutants affect vaccines
New Fred Hutch study looks at whether persistent organic pollutants can undercut vaccines